HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: Healthcare
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
Bedaquiline targets Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other parts of the body, such as the kidneys, spine, and brain. TB is a contagious disease, and it spreads through the air when an infected person coughs, sneezes, or talks, releasing droplets containing…
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
Adalimumab is a medicine that belongs to the class of biologic DMARDs (disease-modifying antirheumatic medications). Humira is a common brand name used in marketing.
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
Semaglutide Semaglutide is a drug developed by Novo Nordisk in 2012, used to treat type 2 diabetes and obesity and is marketed under the brand names Ozempic, Wegovy, and Rybelsus….
-
FDA approved Leqembi to have $12.9 billion sales
Leqembi (lecanemab), a recently approved medicine from Biogen/Eisai for the treatment of Alzheimer’s disease, was given FDA approval in January 2023
-
Assistive Technology Market; a $82B Growth Story
Assistive technology for the elderly refers to devices, tools, and systems designed to support older adults in their daily activities, enhance their independence, and improve their overall quality of life. With the use of assistive technology, people with disabilities can engage in civic activities, the job market, and lead a productive, independent existence. The use…
-
$5000 million Market: Haemophilia Gene Therapy
A bleeding ailment called haemophilia slows down blood clotting process. This syndrome causes prolonged bleeding or oozing to occur after an injury, surgery, or tooth extraction in affected individuals.
-
Respiratory Syncytial Virus; market value at US$9.53 billion
Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that infects the respiratory tract, primarily affecting the lungs and airways.
-
Bulk Drug Park Scheme; Attempt to capture Pharmaceutical Industry to 1.4 trillion USD market
Bulk Drug Park Scheme. Indian pharmaceutical exports include a sizeable portion of bulk medications and intermediates. According to Pharmexil’s Annual Report 2020, the export numbers for APIs range roughly from 3525-3867 million USD during a 3 year period. The three nations receiving the biggest percentages of Indian API exports, both in terms of volume and…
-
5+ Impactful Uses of Enterprise Resource Planning (ERP) System in Healthcare
ERP for hospital management systems plays a vital role in reducing clinical errors and enhancing operations through increased efficiency and coordinated data analyses. Artificial intelligence (AI) has made a significant impact on the healthcare industry, changing how we identify, treat, and monitor patients.
-
Roctavian – A captivating Haemophilia therapy; 5 advantages and disadvantages
Roctavian, a gene therapy product developed by BioMarin, has been approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of hemophilia A(It is a form of bleeding)
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila